West Pharma (WST) Tops Q2 EPS by 27c; Trims Outlook
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $365.74 +0.20%
EPS Growth %: +13.0%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: +13.0%
Financial Fact:
Equity in net income of affiliated companies: 2.7M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q2 EPS of $2.48, $0.27 better than the analyst estimate of $2.21. Revenue for the quarter came in at $771.3 million versus the consensus estimate of $755.08 million.
GUIDANCE:
West Pharma sees FY2022 EPS of $9.00-$9.12, versus the consensus of $9.32.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Bernstein SocGen Group Downgrades Datadog (DDOG) to Market Perform
- Jefferies Upgrades Yihai International Holding Ltd. (1579:HK) (YNNHF) to Buy
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
